FORMULATION AND IN VITRO EVALUATION OF FAST DISSOLVING TABLET OF VERAPAMIL HYDROCHLORIDE
Objective: The main objective of this research work was to formulate and evaluate fast dissolving tablet of verapamil hydrochloride for the treatment of hypertension.
Methods: In this study, fast dissolving tablet were prepared by wet granulation method by using croscarmellose sodium and sodium starch glycolate as superdisintegrants in the concentration of 2%, 4%, and 6%. Polyvinyl pyrollidone K30 is used as a binder. The designed tablets were subjected to various assessment parameters like friability test, hardness test, disintegration test, wetting time, in vitro drug release and drug content.
Results: All the prepared formulations were subjected to various assessment parameters, and the findings obtain within the prescribed limit. The calibration curve of pure drug using various solvents like distilled water, phosphate buffer pH 6.8 was plotted. F1-F9 containing croscarmellose sodium and sodium starch glycolate in various concentration demonstrate the minimum disintegration time. Among all these formulations F8 shows disintegration time upto 19Â±0.06 seconds due to the high concentration of superdisintegrants. In vitro drug release was tested in phosphate buffer pH 6.8 at a time interval of 0, 1, 3,6,9,12,15 min. The F8 shows drug release 98.5Â±0.567%. Accelerated stability study of optimized formulation (F8) up to 2 mo showed there was no change in disintegration time and percentage drug release.
Conclusion: The results obtained in the research work clearly showed a promising potential of fast dissolving tablets containing a specific ratio of crosscarmellose sodium and sodium starch glycolate as superdisintegrants for the effective treatment of hypertension.Â
2. Sastry SV, Nyshadham JR, FÄ±x JA. Recent technological advances in oral drug delivery. A review. Pharm Sci Technol Today 2000;3:138â€“45.
3. Habib W, Khankari RK, Hontz J. Fast-dissolve drug delivery systems. Crit Rev Ther Drug Carrier Sys 2000;2:61â€“72.
4. Lindgren S, Janzon L. Dysphagia: prevalence of swallowing complaints and clinical finding. Med Clin North Am 1993;3â€“5.
5. Sehgal P, Gupta RG, Singh UK, Chaturvedi A, Gulati A, Sharma M. Fast dissolving tablets: a new venure in drug delivery. Am J Pharm Tech Res 2012;2:253-79.
6. Pahwa R, Gupta N. Orodispersible tablets: superdisintegrants used in an orally disintegrating tablet: a review. Int J Pharma Sci Res 2011;2:2767-80.
7. Bandari S, Mittapalli R, Gannu R, Rao Y. Orodispersible tablets: an overview. Asian J Pharm 2008;2:2-11.
8. Hanawa T. New oral dosage form for elderly patients: preparation and characterization of silk fibroin gel. Chem Pharm Bull 1995;43:284â€“28.
9. Siddiqui M, Garg G, Sharma P. Fast dissolving tablets: preparation, characterization, and evaluation: an overview. Int J Pharm Sci Rev Res 2010;2:87-96.
10. Hirani JJ, Rathod DA, Vadalia RK. Orally disintegrating tablets: a review. Tr J Pharm Res 2009;8:161-72.
11. Sharma N, Sharma J, Jat R, Rathore A. Fast dissolving tablet as a novel dosage form: a review article. In J of Res and Dev In Pharm and Life Sci 2012;12:190-4.
12. Sharma YR. Elementary Organic Spectroscopy, Principles, and Chemical Applications, S. Chand Publication; Reprint; 2016. p. 11-73.
13. Chatwal GR, Anand SK. Instrumental methods of instrumental methods of chemical analysis. 5th Edition. Himalaya Publishing House; 2009. p. 2.49-2.51.
14. Banker GS, Rhodes CT. Optimization techniques in pharmaceutical formulation and processing. In: 4th Ed. Vol. 121. Modern Pharmaceutics. New York; Basal: Marcel Dekkar: 2008. p. 609-10.
15. Bele MH. Pharmaceutics formulation and processing of conventional dosage form. First Edition. Carrer Publication; 2012. p. 48-55, 128-131.
16. Kalia A, Khurana S, Bedi N. Formulation and evaluation of mouth dissolving tablet of oxcarbazepine. Int J Pharm Pharm Sci 2009;1:12-3.
17. Jain C, Naruka P. Formulation and evaluation of fast dissolving tablet of valsartan. Int J Pharm Pharm Sci 2009;1:219-26.
18. Roy A. Orodispersible tablet: a review. Asian J Pharm Chem Res 2016;2:19-26.
19. Indian Pharmacopoeia. Government of India Ministry of Health and Family Welfare, Published by The Indian Pharmacopoeal Commission, Ghaziabad; 2014. p. 2964, 1469, 2143, 2151.
20. Arunachalam A, Lavakumar V, Shankar M. Formulation and in vitro evaluation of levofloxacin oral dispersible tablets. Asian J Res Chem Pharm Sci 2013;1:31-9.
21. Dobetti L. Fast melting tablet: development and technologies. Pharm Tech 2001;2:44-8.
22. Lorenzp Lamosa ML, Cuna M, Vila Jato JL, Torres D. Fast dissolving drug delivery system. J Microencapsul 1997;14:607.
23. Virley P, Zydis YR. A novel fast dissolving dosage form. Manuf Chem 1990;2:36-7.
24. Caretensen JT. Guidelines for drug stability: principles and practices. Third Edition. Marcel Dekkar; 2005. p. 252-5.